T1 Biomarker 1340 1351 Telotristat
T2 Biomarker 1027 1056 temozolomide and capecitabine
T3 Organism 1435 1443 patients
T5 Condition 15 21 tumors
T6 Protein 376 385 molecular
T7 Protein 184 205 bronchopulmonary tree
T8 Gene 169 175  tract
T9 Gene 141 164 gastroenteropancreatic 
T10 Protein 85 106 neuroendocrine system
T11 Biomarker 752 773 lutetium‐177 dotatate
T12 Intervention 689 698 antitumor
T13 Biomarker 775 789 177Lu‐DOTATATE
T14 Disease 1449 1467 carcinoid syndrome
T15 Organism 1268 1287 palliating symptoms
T16 Cellular_component 1356 1370 oral inhibitor
T17 Condition 15 20 tumor
T18 Biomarker 1234 1248 liver‐directed
T19 Organism 569 577 patients
T20 Gene 1374 1396 tryptophan hydroxylase
T21 Condition 822 830 GEP‐NETs
T22 Condition 47 59 malignancies
T23 Biomarker 952 961 sunitinib
T25 Biomarker 671 684 antisecretory
T26 Condition 530 536 tumors
T27 Intervention 153 163 pancreatic
T28 Biomarker 858 868 everolimus
T29 Biomarker 627 639 Somatostatin
T30 Disease 1423 1431 diarrhea
T31 Condition 530 535 tumor
T32 Intervention 984 994 pancreatic
T33 Intervention 836 845 antitumor
T34 Condition 1326 1331 tumor
T35 Gene 447 460 primary sites
